0
0

Stopping Pharma’s Ripoffs and Drug Savings For All Act

3/1/2025, 4:38 AM

Summary of Bill HR 890

Bill 119 HR 890, also known as the "Preventing Double Patenting Act of 2021," aims to amend title 35 of the United States Code in order to address the issue of double patenting. Double patenting occurs when an inventor seeks multiple patents for the same invention, leading to potential abuse of the patent system.

The main goal of this bill is to prevent double patenting by establishing new rules and regulations within the patent system. By doing so, the bill aims to promote fairness and efficiency in the patent process, ultimately benefiting inventors, businesses, and consumers.

In addition to addressing double patenting, the bill also includes provisions for other purposes related to patent law. These additional purposes may include clarifying existing patent laws, improving patent examination procedures, and enhancing the overall effectiveness of the patent system. Overall, Bill 119 HR 890 seeks to make important changes to the patent system in order to prevent double patenting and improve the overall functioning of the patent process. It is an important piece of legislation that aims to protect the integrity of the patent system and promote innovation in the United States.

Congressional Summary of HR 890

Stopping Pharma’s Ripoffs and Drug Savings For All Act

This bill addresses double patenting with respect to drug-related patents. Specifically, the bill requires an owner of drug-related patents, if the owner lists more than one patent as covering a particular drug, to prove in certain proceedings that each patent covers a distinct invention. If the patent owner fails to do so, then the owner shall have disclaimed patent protection from all the listed patents after the first patent expires.

This requirement shall apply to various proceedings challenging the validity of drug-related patents, as well as to infringement lawsuits filed by the patent owner against companies seeking Food and Drug Administration approval for generic or biosimilar versions of patented drugs.

The bill also directs the U.S. Patent and Trademark Office (USPTO) to review its examination procedures to prevent granting multiple patents for the same drug or biological product, unless the patents cover distinct inventions. The USPTO shall report to Congress its findings and recommendations from the review.

Current Status of Bill HR 890

Bill HR 890 is currently in the status of Bill Introduced since January 31, 2025. Bill HR 890 was introduced during Congress 119 and was introduced to the House on January 31, 2025.  Bill HR 890's most recent activity was Referred to the House Committee on the Judiciary. as of January 31, 2025

Bipartisan Support of Bill HR 890

Total Number of Sponsors
2
Democrat Sponsors
2
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 890

Primary Policy Focus

Alternate Title(s) of Bill HR 890

To amend title 35, United States Code, to prevent double patenting, and for other purposes.
To amend title 35, United States Code, to prevent double patenting, and for other purposes.

Comments

Jalen Ford profile image

Jalen Ford

31,083

11 months ago

I don't know much about this bill, but if it helps lower drug prices, then I'm all for it.

Sponsors and Cosponsors of HR 890

Latest Bills

To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.
Bill HR 7391February 11, 2026
To amend the Consolidated Farm and Rural Development Act to reauthorize certain water infrastructure grants, and for other purposes.
Bill HR 7476February 11, 2026
To direct the Administrator of the Federal Emergency Management Agency to submit a monthly report on the status of all projects and activities funded through the Disaster Relief Fund, and for other purposes.
Bill HR 7461February 11, 2026
Electing a Member to a certain standing committee of the House of Representatives.
Bill HRES 1048February 11, 2026
To amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified tuition programs for first home purchases, and for other purposes.
Bill HR 7468February 11, 2026
To authorize civil actions against institutions of higher education and athletic associations that negligently or recklessly permit a biologically male student athlete to compete in an athletic competition intended exclusively for female student athletes, resulting in harm.
Bill HR 7368February 11, 2026
ROUTE Act
Bill HR 6642February 11, 2026
To amend section 477 of the Social Security Act to increase the maximum education and training voucher amount and provide greater support for foster youth pursuing postsecondary education.
Bill HR 7463February 11, 2026
Recognizing the cultural and historical significance of Mardi Gras and the celebration's origins in Mobile, Alabama.
Bill HRES 1051February 11, 2026
Home School Graduation Recognition Act
Bill HR 6392February 11, 2026